Causal association of cholesterol metabolism-related proteins with hepatocellular carcinoma and dysfunction-associated steatotic liver disease: a mendelian randomization study
Abstract Background Dysregulation of cholesterol metabolism has been recognized as a critical driver in the pathogenesis of hepatic disorders, particularly hepatocellular carcinoma (HCC) and metabolic dysfunction-associated steatotic liver disease (MASLD). However, the causal relationships between c...
Saved in:
| Main Authors: | Dianzhe Tian, Shitao Jiang, Yaoge Liu, Han Zheng, Lei Zhang, Yiyao Xu, Xin Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02321-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cholesterol and the gut-liver axis: unraveling their role in the onset and progression of metabolic-associated steatotic liver disease
by: Luis A. Rodríguez-Rojas, et al.
Published: (2025-08-01) -
Applicability of Statins in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
by: Thaninee Prasoppokakorn
Published: (2025-01-01) -
Association between trans-palmitoleic acid and metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma: NHANES 1999–2018
by: Qirui Li, et al.
Published: (2025-06-01) -
Genome-Wide DNA Methylation Markers Associated With Metabolic Liver Cancer
by: Samuel O. Antwi, et al.
Published: (2025-01-01) -
Development of a novel diagnostic model to monitor the progression of metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma in females
by: Xiaoning Gan, et al.
Published: (2024-12-01)